Furthermore, drugs used for the treatment of bone metastasis, which inhibit the OPG/RANKL/RANK pathway, have been reported to cause other toxicities including osteo-necrosis of the jaw and hypocalcemia (19,20). This evidence concerns the gene TNFRSF11A and bone metastasis.